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ABSTRACT
The aim of this research was to investigate antimicrobial and cytotoxic activity of Indonesian
ascidians. Extracts prepared from the Indonesian ascidians namely Lissoclinum patella,
Oxycoryna fascicularis, Didemnum molle and Botryllus schlosseri were assessed for antimicrobial and cytotoxic properties. Antibacterial activity of the extracts was tested against
two Gram-positive bacteria, viz. Bacillus subtilis ATCC 6633 and Staphylococcus aureus
ATCC 25923, and three Gram-negative bacteria, viz. Escherichia coli ATCC 25922,
Vibrio cholerae ATCC 14035 and Pseudomonas aeruginosa ATCC 101454 using the disk
diffusion test. Antifungal activity was also tested against Candida albicans ATCC 10231 and
Aspergillus niger ATCC 16404. The minimum inhibitory concentrations (MICs) of potential
ascidian extracts were determined by the microdilution technique. Cytotoxicity of the extracts
was assessed using the brine shrimp lethality bioassay. By comparing the inhibition zones in
the disk diffusion test, the most active anti-bacterial activity against Gram-positive bacteria
(S. aureus and B. subtilis) was found in the crude extracts of Oxycoryna fascicularis and
Didemnum molle. Lissoclinum patella extract showed the highest activity against the Gramnegative bacteria E. coli and V. cholerae. The LC50 values of the crude extracts of Lissoclinum
patella, Didemnum molle, Botryllus schlosseri, and Oxycoryna fascicularis were 74.3, 97.2,
114.7 and 132.9 μg/ml, respectively. In our study, the most promising species for antimicrobial and cytotoxic properties were Lissoclinum patella and Didemnum molle.
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INTRODUCTION
The marine environment becomes a new focus of
natural product drug discovery because of its relatively
unexplored biodiversity compared to terrestrial
environment (Malve, 2016). Available resources for
pharmacy can be found in the coral reef communities
such as algae, soft coral, sponge, ascidian, marine
microorganism, etc (Abdillah et al., 2015; Deepa et
al., 2017; Ramos et al., 2016). Bio-prospection of
marine natural products is one of the main interest of
pharmaceutical research such as antibacterial, antiviral,
antifungal, cytotoxic activity (Castro-Carvalho et al.,
2017).
Sessile filter-feeding chordates known as ascidians are an
important structural component of coral reef communities.
They populate marine ecosystems, whether in tropical,
subtropical or temperate waters. Ascidians have been
the source of a wide variety of secondary metabolites,
some of which have physiological functions, mainly in
defense against their natural predators (Joullié et al.,

2003; Paul et al., 1990; Pisut & Pawlik, 2002)northern
Sulawesi (Indonesia. While research efforts in bioactive
metabolites from marine ascidians are relatively recent,
some chemical compounds from marine ascidians
are being evaluated as antitumor agents in preclinical
and clinical trials. The most prominent example of an
ascidian-derived drug is trabectedin or ecteinascidin
743 (ET-743, Yondelis®), an alkaloid isolated from the
Caribbean ascidian Ecteinascidia turbinate. This is the
first marine-derived drug to be prescribed against soft
tissue carcinoma (Cuevas & Francesch, 2009; Gordon et
al., 2016; Menna, 2009).
It has been demonstrated that 7% of the compounds
isolated from ascidians are produced by symbiotic
bacteria, leaving the exact biosynthetic source of the
remaining 93% of described metabolites unknown
(Schmidt & Donia, 2010; Tianero et al., 2015). Many
anti-microbial compounds have been isolated from
ascidians or ascidian-associated marine bacteria.
Antibacterial activity was observed in brominated
rubrolides isolated from an African ascidian Synoicum
ISSN 2407-2354

66

Pharm Sci Res, Vol 5 No 2, 2018

Karim, et al.

globosum (Sikorska, Parker-Nance, et al., 2012).
Peptidolipins, which are lipopeptide compounds
produced by bacteria (Nocardia sp.) from the Florida
Keys tunicate Trididemnum orbiculatum, showed
activity against methicillin-sensitive Staphylococcus
aureus (MSSA) and methicillin-resistant Staphylococcus
aureus (MRSA) (Wyche et al., 2012).
In the present study, investigations were undertaken
on marine invertebrates from coastal areas of the
Indonesian archipelago, one of the world’s hotspots
of marine biodiversity. We examined organic extracts
from some of the most abundant marine ascidians in the
Buton islands, Southeast Sulawesi, namely Lissoclinum
patella, Oxycoryna fascicularis, and Didemnum molle.
We also investigated crude extracts of the ascidian
Botryllus schlosseri collected from Selayar Island, South
Sulawesi, for their anti-microbial and cytotoxic effects.
Using the disk diffusion assay, the anti-bacterial activity
of ascidian extracts was tested against five human
pathogenic bacteria, viz. Staphylococcus aureus (ATCC
25923), Bacillus subtilis (ATCC 6633), Eschericia coli
(ATCC 25922), Vibrio cholerae (ATCC 14035), and
Pseudomonas aeruginosa (ATCC 10145). Antifungal
activity was similarly tested against Candida albicans
(ATCC 10231) and Aspergillus niger (ATCC 16404). We
also used the brine shrimp lethality bioassay to test for
cytotoxic activity.
MATERIALS AND METHODS
Ascidian Sample Collection and Extraction
Three ascidians, Lissoclinum patella, Oxycoryna
fascicularis, and Didennum molle, were collected in July
2016 at a depth of 1-5 m by scuba diving from two sites
of the Buton Islands, Southeast Sulawesi, Indonesia. The
ascidian Botryllus schlosseri was collected in June 2015
at a depth of 5-10 m from Selayar Island, South Sulawesi
(Table 1). A voucher record of each specimen (ASC1BT, ASC2-BT, ASC3-BT, ASC1-SLY) was deposited
at the Research Center for Oceanography of Indonesian
Institute of Science. Each ascidian sample of 150-200
g wet weight was cut into small pieces, homogenized

and extracted three times with MeOH-CHCl3 (3:1)
at room temperature overnight. Following this, the
crude extracts were concentrated by evaporation under
reduced pressure.
Antimicrobial Assays
Disk Diffusion Assay
Antibacterial activity of the ascidian extracts was
assessed using the agar disk diffusion test6. Five
reference strains of human pathogens were used in the
assays, viz. two Gram-positive bacteria (Staphylococcus
aureus ATCC 25923, Bacillus subtilis ATCC 6633) and
three Gram-negative bacteria (Eschericia coli ATCC
25922, Vibrio cholerae ATCC 14035, Pseudomonas
aeruginosa ATCC 10145). The bacteria were grown
in liquid marine broth medium for 24 hours at room
temperature. The various ascidian extracts were adjusted
to a concentration of 100 µg/mL in MeOH and 20 μl of
each extract was pipetted on to a sterile paper disk (6
mm diameter) and allowed to dry. A reference control
paper disk carried 10 µg ampicillin in 20 μl MeOH. The
paper discs were then placed on Mueller Hinton Agar
(Himedia) in a petri dish that had been inoculated with
the test bacteria (107 CFU/mL). The inhibition zone that
appeared was recorded after 24 h incubation at 30°C. All
the assays were carried out in triplicate.
Candida albicans ATCC 10231 and Aspergillus niger
ATCC 16404 were used as test fungi and inoculated on
to Sabouraud Dextrose Agar (fungus) plates (104 CFU/
mL). The various ascidian extracts were adjusted to a
concentration of 100 µg/mL and 20 μl of each extract was
pipetted on to 6 mm sterile paper disks. The discs were
allowed to dry and then placed on Sabouraud Dextrose
Agar. The inhibition zone was recorded after incubation
at room temperature (25 °C) for 48 h. Nystatin (30 mg/
disc) was used as the positive control and methanol as
the solvent control. All the assays were performed in
triplicate.
Microdilution Method
The microdilution method was used to evaluate the

Table 1. Ascidians Species and Place of Collection

(Southeast

Voucher Specimen
Number
ASC1-BT

(Southeast

ASC2-BT,

(Southeast

ASC3-BT

(South Su-

ASC1-SLY

Sponge Species

Depth (m)

Place of Collection

Lissoclinum patella

1-5 m

Oxycoryna fascicularis

1-5 m

Didennum molle

1-5 m

Botryllus schlosseri

5-10 m

Buton Island
Sulawesi)
Buton Island
Sulawesi)
Buton Island
Sulawesi)
Selayar Island
lawesi)
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minimum inhibitory concentration (MIC) of the ascidian
extracts which displayed high activity (growth inhibition
halos more than 9 mm.) Tests were performed in 96-well
round bottom sterile culture plates using the Infinite®
200 PRO microplate reader (Tecan Austria GmbH).
The assay plates were filled with Mueller-Hinton broth
medium (MHB) containing different concentrations
(62.5, 125, 250, 500 µg/ml) of Lissoclinum patella
extract, Oxycoryna fascicularis extract, Didemnum molle
extract, ampicillin or solvent control, as well as the test
microorganism (107 CFU/mL). After a 24 h incubation
period at 37 °C, the turbidity in each well was measured
at 600 nm.
MIC for fungal strains was also performed using the 96well plate. Each well contained potato dextrose broth,
different concentrations of Lissoclinum patella estract,
Didemnum molle extract, Nystatin or solvent control, as
well as the test yeast strain (104 CFU/mL). Incubation
was performed at room temperature (18-20 °C) for 48
h. The yeast growth was measured at 494 nm using the
Infinite® 200 PRO microplate reader (Tecan Austria
GmbH).
Brine Shrimp Lethality Bioassay
Different concentrations (10, 100, 1000 mg/ml) of the
ascidian crude extracts were prepared for cytotoxic
activity test using the brine shrimp lethality bioassay.
Brine shrimp eggs (Artemia salina) were placed in a
hatching tank containing 1 L of seawater under aeration
at room temperature to hatch under continuous light.
After 24 h, ten brine shrimp larvae were placed in
a small container filled with sea water and different
concentrations of the extracts. Survivors (instar III/
IV stage) were calculated after 48 h incubation, and
the mortality percentage for each concentration and
the control (seawater) was determined. Treatments and
controls were prepared in triplicates.
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Statistical Analysis
Measurements in all the experimental analyses were
expressed as mean ± SD (n = 3). Results of the research
were tested for statistical significance with One-way
ANOVA. Differences were considered statistically
significant at the P < 0.05 level. The statistical software
package SPSS v.16 (SPSS Inc., Chicago, IL, USA) was
used for the analysis.
RESULTS AND DISCUSSION
Antimicrobial Properties
The results of the agar disk diffusion assay on the crude
ascidian extracts against five bacteria (Staphylococcus
aureus ATCC 25923, Bacillus subtilis ATCC 6633,
Escherichia coli ATCC 25922, Vibrio cholerae ATCC
14035, Pseudomonas aeruginosa ATCC 10145) and
two strains of fungus (Candida albicans ATCC 10231
and Aspergillus niger ATCC 16404) are presented in
Table 2. All the ascidian extracts showed potential antimicrobial activities against at least one of the test strains.
By comparing the inhibition zones, the most active antibacterial activity against Gram-positive bacteria (S.
aureus and B. subtilis) was shown for the crude extracts
of Oxycoryna fascicularis and Didemnum molle. Against
S. aureus, Oxycoryna fascicularis and Didemnum
molle produced inhibition zones of 9.10 and 9.20 mm,
respectively. Moreover, against B. subtilis, Oxycoryna
fascicularis and Didemnum molle showed inhibition
zones of 9.20 and 10.2 mm, respectively.
Lissoclinum patella extract was found to possess the
highest activity against Gram-negative bacteria (E.
coli and V. cholerae), with inhibition zones of 9.20
and 9.1 mm, respectively. All ascidian extracts showed
moderate activity against the Gram-negative bacterium
P. aeruginosa. Based on the results from the anti-fungal
assays, Didemnum molle demonstrated the highest

Table 2. Antimicrobial Activity of Marine Ascidian Extracts Determined by the Disk Diffusion Assay
Species
Lissoclinum
patella
Oxycoryna
fascicularis
Didemnum
molle
Botryllus
schlosseri
Ampicillina
Nystatin

a

Inhibition Zone (mm)
S. aureus

B. subtilus

E. coli

V. cholerae

P. aeruginosa

C. albicans

A. niger

6.80

7.50

9.20

9.10

3.30

4.8

4.3

9.10

9.20

8.00

4.60

2.10

5.2

5.8

9.2

10.2

8.1

8.5

5.3

9.1

4.2

8.60

7.30

0

3.60

4.50

3.7

4.1

30.60

18.8

29.30

23.9

23.5

-

-

-

-

-

20.3

15.4
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Table 3. Minimum Inhibitory Concentrations (MICs in µg/ml) of Marine Ascidian Extracts
Microorganisms
Ascidian
extracts
Lissoclinum
patella
Oxycoryna
fascicularis
Didemnum
molle

S. aureus

B. subtilus

E. coli

V. cholerae

-

-

250

250

125

250

250

-

250

125

-

-

P. aeruginosa C. albicans A. niger
-

-

-

-

-

250

-

Table 4. Effect of the Extract of Sponges on Brine Shrimp Survival
Acidians
Lissoclinum patella
Oxycoryna fascicularis
Didemnun molle
Botryllus schlosseri

LC50 (μg/mL)
74.336
132.91
97.145
114.709

Figure 1. The Plot of Log Concentration of Crude
Ascidian Extracts vs. Percent of Shrimp Mortality
After 48 H of Exposure (Probits)
inhibitory activity against C. albicans, with an inhibition
zone of 9.1 mm. MICs were determined for the three
ascidian extracts that gave the best results for antibacterial and anti-fungal activities. Results from the
broth microdilution method are summarized in Table 3.
Cytotoxic Activity
Cytotoxic activity of the ascidian extracts was evaluated
using the brine shrimp lethality bioassay. The LC50
values of the crude extract of Lissoclinum patella,
Oxycoryna fascicularis, Didemnum molle and Botryllus
schlosseri were 74.3, 132.91, 97.145 114.71 μg/ml,
respectively (Figure 1, Table 4). Based on the results
from the cytotoxic assay, extracts of Lissoclinum patella
and Didemnum molle were the most promising from the
standpoint of cytotoxic activity.
A large number of natural compounds, especially those
with anti-microbial or cytotoxic properties, have been
extracted from marine invertebrates. Among such marine
invertebrates widely studied are the ascidians, from
ISSN 2407-2354

Regression Equation
y = 5,3818x - 5,0702
Y = 1,6445 + 1.5078
y = 5,5812x - 6,0923
y = 3,9699x - 3,1765

R2
R² = 0.9915
R2 = 0.8028
R² = 0.9281
R² = 0.9714

which a broad range of interesting bioactive compounds,
including those showing anti-bacterial, anti-cancer,
anti-inflammatory and antimalarial properties, have
been extracted. Nonetheless, information on potential
pharmacological characteristics of Indonesian ascidians
remains rare. With the evolution of multiple resistance
among pathogenic microorganisms, the search for
new anti-microbials from alternative sources such as
the marine environment has taken on a new urgency.
We have, accordingly, initiated a program to screen
Indonesian marine ascidians for anti-microbial and
cytotoxic compounds.
Previous anti-microbial screenings have shown Grampositive bacteria to be more sensitive than Gram-negative
bacteria or fungi to extracts of marine invertebrates such
as sponges, and ascidians (Qaralleh et al., 2010; Tadesse
et al., 2008) including the bacteria Staphylococcus
aureus ATCC25923, Bacillus cereus ATCC11778,
Pseudomonas aeruginosa ATCC27853, Escherichia coli
ATCC35218, the yeasts Candida albicans ATCC10231
and Cryptococcus neoformans ATCC90112. All the
sponge species in this study showed antibacterial
activity against at least one bacterial strain and only
one sponge species was significantly active against C.
albicans. P. aeruginosa was considered resistant to all
tested samples, since no inhibition zone was observed
while the Gram-positive B. cereus was shown to be the
most sensitive microorganism followed by C. albicans
and S. aureus. The highest activity was obtained for
the aqueous extract of Neopetrosia exigua against the
Gram-positive bacteria B. cereus (inhibition zone 25mm
and MIC 0.07mg/mL. Our results that find the tested
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extracts showing high activity against Gram-positive
bacteria are, therefore, in agreement with these findings.
Based on these results, extracts from two ascidians,
viz. Lissoclinum patella and Didemnum molle, were
found to be especially promising in their anti-bacterial
action towards Gram-positive bacteria, whereas another
ascidian Oxycorina fascicularis was reactive against
Gram-negative bacteria. Didennum molle appears to
have the greatest potential as an anti-microbial source.
This ascidian was reactive against the Gram-positive
bacteria (S. aureus and B. subtilis) and a fungal pathogen
C. albicans. The anti-microbial activities of the extract
from the genus Didemnum might be due to the presence
of the compounds, Didemnoline A, Didemnoline C or
Didemnaketal F, that are reported to be inhibitory to S.
aureus, B. subtilis and C. albican (Palanisamy et al.,
2017; Schumacher & Davidson, 1999; Shaala et al.,
2014) while didemnolines B (2. The extract from another
ascidian, Lissoclinum patella, also showed an apparent
specificity towards Gram-positive bacteria.
This
genus is known to contain the anti-bacterial compound
Lissoclinotoxins (Litaudon et al., 1994).
Gram-positive bacteria tend to be more sensitive to drug
action than Gram-negative bacteria (Cos et al., 2006;
Malanovic & Lohner, 2016; Mcdonnell & Russell,
1999)many of which have been used for hundreds of
years, including alcohols, phenols, iodine, and chlorine.
Most of these active agents demonstrate broad-spectrum
antimicrobial activity; however, little is known about
the mode of action of these agents in comparison to
antibiotics. This review considers what is known about
the mode of action and spectrum of activity of antiseptics
and disinfectants. The widespread use of these products
has prompted some speculation on the development of
microbial resistance, in particular whether antibiotic
resistance is induced by antiseptics or disinfectants.
Known mechanisms of microbial resistance (both
intrinsic and acquired. The former, such as S. aureus,
are significant pathogens in hospital environments. For
this reason, new anti-bacterial agents useful for treating
serious Gram-positive infections are in demand.
Several cytotoxic compounds such as cyclic peptides,
diterpenes, and alkaloids have been isolated from ascidian
Lissoclinum patella and Didemnum molle (Donia et al.,
2008; Rashid et al., 1995; Sikorska, Hau, et al., 2012;
Teruya et al., 2008). These compounds are cytotoxic
against various tumor cell lines, and they are considered
potential lead compounds for the development of new
anticancer agents.
The brine shrimp bioassay is broadly accepted as a useful
indicator of potential cytotoxic activity in terrestrial
plants and marine organisms. This assay, which has been
shown to correlate well with cytotoxicity in cancer cell
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lines such as 9KB, P388, L5178Y and L1210 (De Rosa
et al., 1994; Mclaughlin et al., 1998)to establish relevant
structure-activity relationships (SAR, has the benefits
of simplicity, low cost and reliability in assessing
cytotoxicity. In our study that employed the assay,
Lissoclinum patella and Didemnum molle were the most
promising in their cytotoxic activity.
CONCLUSION
Indonesian marine ascidians were shown to possess
anti-microbial and cytotoxic activities. In our study, the
most promising species for anti-microbial and cytotoxic
properties were Lissoclinum patella and Didemnum
molle. Extracts from these organisms will be further
subjected to bioassay-guided fractionation to isolate the
active compounds responsible for these properties of
pharmacological relevance.
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